These graphs compare the performance of the biotech stocks for all of 2025 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Biocomposites, Eyas, Insightec, Mirum, Sonorous Neurovascular.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Apotex, Chemometec, Eisai, Grünenthal, Henlius, Endomimetics, Everest, Factor, Imunon, Liger, Micot, Phase Scientific, Roche, Searchlight, Tempest, Watchmaker, Visby, Vectus, Xortx.

Clinical updates for biopharma and med tech, including data readouts and publications: Aicuris, Alvotech, Ayrmid, Exicure, Pentixapharm.

Biopharma and med-tech companies raising money in public or private financings, including: Angitia, Collplant, GE Medical Holding, Generate, Exact, Inspira, LB, Myndtec.

New hires and promotions in the biopharma and med-tech industries, including: Adarx, Angitia, Braveheart, Calico, Iveena, Polaryx, Primmune, Renovorx, Tempest, Vectory.

Biopharma money raised to-date and by month in 2025, including public, private and other financings.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acarix, Balt, Cumberland, Hologic, Ingeneron, Oncolytics, TSC.